TABLE 1.
Our Patients’ Demographic and Clinical Information
| Total (N = 94) | Men (N = 36) | Women (N = 58) | |
|---|---|---|---|
| Age (years) | 69.2 (6.8) | 69.9 (7.0) | 68.7 (6.7) |
| Education (years) | 10.5 (3.2) | 9.9 (3.9) | 10.9 (2.6) |
| Number of medications | 10 [0–22] | 10 [0–21] | 11 [0–22] |
| Hypertension | 95.7% | 91.7% | 98.3% |
| Diabetes | 60.2% | 50% | 66.7% |
| Hypercholesterolemia | 21.8% | 18.2% | 24.1% |
| History of stroke | 13.8% | 19.4% | 10.3% |
| Obesity* | 52.2% | 36.1% | 62.5% |
| Mini-Mental State Examination†1 | 25.51 (3.54) | 24.08 (4.09) | 26.40 (2.84) |
| Computer Assessment of Mild Cognitive Impairment2 | |||
| Attention | 82.09 (22.57) | 78.24 (24.82) | 84.48 (20.91) |
| Executive function | 42.47 (19.15) | 40.43 (17.49) | 43.74 (20.15) |
| Verbal memory† | 29.79 (30.73) | 18.89 (23.88) | 36.55 (32.69) |
| Functional memory | 47.16 (25.36) | 43.06 (25.93) | 49.71 (24.88) |
| Incidental memory | 35.7 (20.82) | 32.22 (17.42) | 37.89 (22.58) |
Descriptive statistics are presented as mean (standard deviation) for continuous variables, median [range] for count variables, and percentage for dichotomous variables.
Results remained the same when we counted the two excluded patients who had 30 or more medications.
The difference between sexes was statistically significant at *P < 0.05 or †P < 0.01.